ASCO 2018

The Epic Sciences team will be attending the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL from June 1st - 5th, 2018.

Oral Presentation:

Abstract 5004 - The prophecy trial: Multicenter prospective trial of circulating tumor cell (CTC) AR-V7 detection in men with mCRPC receiving abiraterone (A) or enzalutamide (E) - June 2, Hall A, 1:15 PM – 4:45 PM

Posters:

Abstract 5054 - Clonal concordance and genomic heterogeneity in single CTC copy number alterations vs. paired IMPACT metastatic tissue sequencing from mCRPC patient samples - June 2, Hall A, 1:15 PM – 4:45 PM
Abstract 5012 - Phenotypic and genomic characterization of CTCs as a biomarker for prediction of velipardib therapy benefit in mCRPC - June 2, Hall A, 1:15 PM – 4:45 PM
Abstract 5053 - Unique patterns of the selection and changing in circulating tumor cells (CTC) phenotypes and genotypes by the drug class in metastatic castration resistant prostate cancer (mCRPC) - June 2, Hall A, 1:15 PM – 4:45 PM
Abstract 1084 - Analysis of Circulating tumor cells (CTCs) in patients across multiple metastatic breast cancer (mBCa) cohorts identifies marked inter- and intra- patient heterogeneity in CTC size, shape, and overall morphology - June 2, Hall A, 8:00 AM – 11:30 AM

Please contact us if you would like to set up a meeting while we are there